Zdrowie i gospodarka · 16/07/2002

FDA Announces Submission of Proposed Collection of Information for In Vivo Radiopharmaceuticals to OMB for Review

The Food and Drug Administration (FDA) is requesting public comment on a proposed collection of information related to regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.